Skip to content

Clinical trials

Overweight trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Singapore Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20181
20191
20201
20213
20222
20231
20241
20256
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting6
Unknown status6
Active, not recruiting3
Not yet recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company9
Nanyang Technological University4
National University Hospital, Singapore3
National University of Singapore2
Noah Lim2
Alexandra Hospital1
Amgen1
KK Women's and Children's Hospital1
National University Health System, Singapore1
Singapore General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight26
Obesity24
Diabetes Mellitus, Type 24
Weight Loss3
Alopecia1
Atherosclerosis1
Body Weight1
Diabetes Mellitus1
Hyperlipidemias1
Hypertension1

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.